Synthaverse S.A. (WSE:SVE)

Poland flag Poland · Delayed Price · Currency is PLN
3.010
+0.015 (0.50%)
May 21, 2026, 5:00 PM CET
Market Cap211.96M -35.8%
Revenue (ttm)42.01M -30.6%
Net Income-19.93M
EPSn/a
Shares Out70.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume82,943
Average Volume86,923
Open2.985
Previous Close2.995
Day's Range2.940 - 3.010
52-Week Range2.970 - 5.910
Beta0.16
RSI27.96
Earnings DateApr 30, 2026

About Synthaverse

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50 and BCG 100 products for treating superficial (non-muscle invasive) bladder tumor; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunog... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1944
Employees 239
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SVE
Full Company Profile

Financial Performance

Financial Statements